You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycated Hemoglobin A

Showing 1 - 25 of 3,121
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes Trial in Cairo (1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin ratio)

Recruiting
  • Diabetes Mellitus
  • 1,5 Anhydroglucitol and 1,5 Anhydroglucitol / Glycated Hemoglobin ratio
  • Cairo, Manial, Egypt
    Cairo University
Mar 22, 2022

Trajectories of Fatigue and Quality of Life in People With Both

Not yet recruiting
  • Pancreatic Cancer Resectable
  • Diabetes Mellitus
    • (no location specified)
    Aug 22, 2023

    Diabetes, Prostatic Hyperplasia Trial in Cairo (International prostate symptom score, Assessment of prostate volume, Pittsburgh

    Completed
    • Diabetes Mellitus
    • Prostatic Hyperplasia
    • International prostate symptom score
    • +3 more
    • Cairo, Egypt
    • +1 more
    Nov 19, 2023

    Width and HbA1C in Type 2 Diabetes Mellitus After Glycemic

    Not yet recruiting
    • Type 2 Diabetes
    • Glycated hemoglobin (HbA1C)
    • +2 more
    • (no location specified)
    Sep 28, 2023

    Diabetes, Type 2 Trial in Bogotá (Point of Care - Glycated Hemoglobin (A1c), Oral Glucose Tolerance Test)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Point of Care - Glycated Hemoglobin (A1c)
    • Oral Glucose Tolerance Test
    • Bogotá, Colombia
      Maria Granados
    Jul 5, 2022

    Blood Markers of Early Pancreas Cancer

    Recruiting
    • Diabetes Mellitus, Type 2
    • +5 more
    • Mixed Meal Tolerance Test
    • +2 more
    • Omaha, Nebraska
      Nebraska Medical Center
    Jan 31, 2022

    Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)

    Active, not recruiting
    • Diabetes Mellitus Type 2
    • Doha, Qatar
      Hamad Medical Corporation
    Apr 27, 2022

    HCL Insulin Delivery System on Glycemic Control in T1D

    Recruiting
    • Diabetes Mellitus, Type 1
    • Tandem t:slim X2 with hybrid closed loop system Control IQ, glucose sensor: Dexcom G6
    • MiniMed 780G, with hybrid closed loop system SmartGuard, sensor Guardien 4
    • Usti Nad Labem, Czechia
      Lucie Radovnická
    Jun 21, 2023

    Long-term, Implantable Sensor Improves Health Outcomes in T1D

    Completed
    • Diabetes Mellitus, Type 1
    • Long term sensor
    • Catanzaro, Italy
      University Magna Graecia
    Nov 8, 2019

    Type 2 Diabetes Trial in Washington (plant-based diet)

    Not yet recruiting
    • Type 2 Diabetes
    • plant-based diet
    • Washington, District of Columbia
      Physician Committee for Responsible Medicine
    Oct 5, 2022

    HbA1c Variation Study

    Recruiting
    • Diabetes Mellitus
    • HBA1c data and glucose levels
    • Billings, Montana
    • +10 more
    Aug 2, 2022

    HELICOBACTER PYLORI INFECTION IN TYPE 2 DIABETES MELLITUS IN

    Not yet recruiting
    • H Pylori Infection
    • ALL PATIENT DIABETIC IN THIS PERIOD WILL BE INCLUDED IN THE STUDY
    • (no location specified)
    Mar 16, 2023

    Diabetes, Type 2 Trial in Worldwide (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Canagliflozin 100 mg
    • +2 more
    • Little Rock, Arkansas
    • +121 more
    Aug 18, 2022

    Type1 Diabetes, Obesity Trial in Milan (Microbiome-targeted diet, Usual care diet)

    Recruiting
    • Type1 Diabetes
    • Obesity
    • Microbiome-targeted diet
    • Usual care diet
    • Milan, Milano, Italy
    • +1 more
    Mar 1, 2023

    Type 2 Diabetes Trial in Guangzhou (Text messaging)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • Text messaging
    • Guangzhou, Guangdong, China
      Nanfang Hospital of Southern Medical University
    Apr 5, 2022

    Vitamin D Deficiency Trial in Amman (VD3 group, omega 3 FA group, VD3 and omega- 3FA group)

    Completed
    • Vitamin D Deficiency
    • VD3 group
    • +3 more
    • Amman, Jordan
      Applied Science University
    Jul 16, 2019

    COVID-19 Pandemic on Cardiovascular Risk Factors in Diabetes

    Completed
    • Diabetes Mellitus
    • Covid19
    • No intervention
    • Ostrava, Czechia
      University Hospital Ostrava
    Dec 6, 2022

    Type 1 Diabetes Trial in Canada, United States (Insulin glargine, 300 units per milliliter (U/mL), Background therapy: Rapid

    Terminated
    Has Results
    • Type 1 Diabetes Mellitus
    • Insulin glargine, 300 units per milliliter (U/mL)
    • Background therapy: Rapid Acting meal time insulin analogs (Humalog, Novolog or Apidra)
    • West Des Moines, Iowa
    • +5 more
    Mar 24, 2022

    Diabetes, Type 2, Overweight or Obesity Trial in Ningbo (lifestyle intervention)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Overweight or Obesity
    • lifestyle intervention
    • Ningbo, Zhejiang, China
      Ningbo First Hospital
    Sep 27, 2022

    T1D, Metabolic Syndrome and Insulin Resistance

    Completed
    • Type 1 Diabetes
    • +2 more
      • Villahermosa, Tabasco, Mexico
        Isela Esther Juarez Rojop
      Aug 13, 2022

      Type 2 Diabetes, PreDiabetes, Hypertension Trial in Worldwide (mHealth intervention, Standard care)

      Recruiting
      • Type 2 Diabetes
      • +2 more
      • mHealth intervention
      • Standard care
      • Tirana, Rruga E Dibrës, Albania
      • +3 more
      Dec 5, 2022

      Stroke Trial in New Taipei City, Taipei city (Bifidobacterium longum OLP-01, Placebo)

      Active, not recruiting
      • Stroke
      • Bifidobacterium longum OLP-01
      • Placebo
      • New Taipei City, Taiwan
      • +2 more
      Jul 25, 2022

      Pre Diabetes Trial in Derby (Fos Biomedical patch product, Fos Biomedical patch product:)

      Active, not recruiting
      • Pre Diabetes
      • Fos Biomedical patch product
      • Fos Biomedical patch product:placebo
      • Derby, Connecticut
        Yale-Griffin Prevention Research Center
      Nov 16, 2022

      Diabetes, Type 2 Trial in Porto Alegre (Active comparator Taurine, Placebo Comparator)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Active comparator Taurine
      • Placebo Comparator
      • Porto Alegre, Rio Grande Do Sul, Brazil
        Hospital de Clínicas
      Jan 21, 2022

      IDH in Diabetic Haemodialysis Patients and Association With

      Unknown status
      • Intra-dialytic Hypotension
      • glycated hemoglobin
      • (no location specified)
      Mar 8, 2019